Head and Neck Cancer New Indication: Axitinib and Avelumab for Adenoid Cystic Carcinoma Ulas D. Bayraktar, MD 2023-04-14
Uterine Cancer New Indication: Trastuzumab Deruxtecan for her2-Expressing Advanced Uterine Cancer Ulas D. Bayraktar, MD 2023-04-14
Pancreatic Cancer New Indication: Sotorasib in kRAS G12C Mutant Pancreatic Cancer Ulas D. Bayraktar, MD 2023-03-15
Non-Small Cell Lung Cancer New Indication: Adjuvant Pembrolizumab for NSCLC Ulas D. Bayraktar, MD 2023-03-15
Colorectal Cancer New Protocol: Tucatinib and Trastuzumab for Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Bladder Cancer New Reference: Neoadjuvant CISplatin and Gemcitabine for Urothelial Cancer Ulas D. Bayraktar, MD 2023-03-15
Breast Cancer New Indication: Sacituzumab Govitecan for HR+, her2 Negative Breast Cancer Ulas D. Bayraktar, MD 2023-03-15
